Düzeltme

Novel microbiome friendly purifying oil cleanser formulation with oil-soluble postbiotics

Cilt: 10 Sayı: 1 13 Haziran 2025
PDF İndir
TR EN

Novel microbiome friendly purifying oil cleanser formulation with oil-soluble postbiotics

Bu makalenin ilk hali 14 Şubat 2025 tarihinde yayımlandı. https://dergipark.org.tr/tr/pub/jicm/article/1580770

Düzeltme Notu

Corrigendum was created due to the correct arrangement of the author order in line with the request of the authors and the addition of a thank you letter. ACKNOWLEDGEMENT The realization of this research project was made possible by the cooperation of Technopark Development Zone-University and Industry. The authors would like to express their gratitude to The Purest Solutions Purifying Oil Cleanser with Postbiotics manufacturer EVLY Pharma Cosmetics Inc. and TPS Academy for their support.

Öz

Objective: In recent years, the field of preventive cosmetic care has gained importance alongside the established effectiveness of nutrition in preventing diseases. Within the scope of this preventive approach, the microbiota has been a focal point in numerous studies, with its state being associated with a range of health concerns, including inflammation, metabolic diseases, dermatological diseases, and neurodegenerative diseases.The present study aims to investigate the positive effects of a cleanser formulated with a postbiotic raw material dissolved in oil on skin microbiota and cells. In this study, the skin cleansing oil containing 2% postbiotic LTO 35 was utilised as a skin microbiota simulation (Lactobacillus crispatus LTC-KC24011, Staphylococcus epidermidis ATA-LSE 0198052) and normal keratinocytes (HEKA 500K CELL), Staphylococcus aureus ATA-LTCA 011204, Staphylococcus capitis ATA-LSC 0201201, Propionibacterium acnes ATA-LPC 0204221, Streptococcus pyogenes ATA-TCSP 210911, and Candida albicans ATA-LTCA 0504212. The results demonstrated that the cleanser did not cause harm to keratinocytes, maintained microbiota balance, and promoted cellular repair.The objective of this study was to investigate the positive effects of a cleanser made using oil-solubilised postbiotic raw material on skin microbiota and cells. Material&Method: In this study, a skin cleansing oil containing 2% postbiotic LTO 35 was utilised to simulate normal keratinocytes (HEKA 500K CELL) and skin microbiota (Lactobacillus crispatus LTC-KC24011, Staphylococcus epidermidis ATA-LSE 0198052, Staphylococcus aureus ATA -LTCA 011204, Staphylococcus capitis ATA-LSC 0201201, Propionibacterium acnes ATA-LPC 0204221, Streptococcus pyogenes ATA TCSP 210911, Candida albicans ATA-LTCA 0504212. The bacteria utilised in the simulation and the postbiotic employed in the formulation (LTO 35 Streptococcus thermophilus ATA-LTC St140700, Bifidobacterium animalis ATA-BSLA0310, Lactobacillus acidophilus ATA-LAP1201 ferment extract in oil lysate) were obtained from the ATA BIO Technology culture collection. The simulation contact time was applied as 1 hour. Results: The Purifying Oil Cleanser with Postbiotics sample examined in this study was found to be microbiologically suitable. The equilibrium test yielded a positive result, and it was observed that the sample did not change in the direction of pathogens. According to the analyses, it can be concluded that the Purifying Oil Cleanser with Postbiotics sample does not harm the diversity of skin microbiota and is microbiome-friendly. Conclusion: Upon evaluation of the results, it was observed that the substance did not cause harm to keratinocytes, it maintained microbiota balance, and it promoted cellular repair.

Anahtar Kelimeler

Teşekkür

The realization of this research project was made possible by the cooperation of Technopark Development Zone-University and Industry. The authors would like to express their gratitude to The Purest Solutions Purifying Oil Cleanser with Postbiotics manufacturer EVLY Pharma Cosmetics Inc. and TPS Academy for their support.

Kaynakça

  1. Prescott SL, Larcombe DL, Logan AC, West C, Burks W, Caraballo L, et al. The skin microbiome: impact of modern environments on skin ecology, barrier integrity, and systemic immune programming. World Allergy Organ J. 2017;10:1-16.
  2. Roy S, Dhaneshwar S. Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: Current perspectives. World J Gastroenterol. 2023;29(14):2078.
  3. Zhao X, Liu S, Li S, Jiang W, Wang J, Xiao J, et al. Unlocking the power of postbiotics: A revolutionary approach to nutrition for humans and animals. Cell Metab. 2024;36(4):725-44.
  4. Aguilar-Toalá JE, Garcia-Varela R, Garcia HS, Mata-Haro V, González-Córdova AF, Vallejo-Cordoba B, et al. Postbiotics: An evolving term within the functional foods field. Trends Food Sci Technol. 2018;75:105-14.
  5. Taverniti V, Guglielmetti S. The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept). Genes Nutr. 2011;6(3):261-74.
  6. Patel RM, Denning PW. Therapeutic use of prebiotics, probiotics, and postbiotics to prevent necrotizing enterocolitis: what is the current evidence?. Clin Perinatol. 2013;40(1):11-25.
  7. Sionek B, Gantner M. Probiotics and Paraprobiotics—New Proposal for Functional Food. Appl Sci. 2025;15(1).
  8. Oleskin AV, Shenderov BA. Microbial Communication and Microbiota-Host Interactivity: Neurophysio-logical, Biotechnological, and Biopolitical Implications. Hauppauge, NY: Nova Science Publishers; 2020.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Tıbbi Mikrobiyoloji (Diğer)

Bölüm

Düzeltme

Erken Görünüm Tarihi

2 Mart 2025

Yayımlanma Tarihi

13 Haziran 2025

Gönderilme Tarihi

31 Aralık 2024

Kabul Tarihi

-

Yayımlandığı Sayı

Yıl 2025 Cilt: 10 Sayı: 1

Kaynak Göster

APA
Aslan, İ., Tarhan Çelebi, L., Bursalıoğlu, E., Çakıcı, B., Arslan Aydin, M., Ibrahim, B., & Kurt, A. A. (2025). Novel microbiome friendly purifying oil cleanser formulation with oil-soluble postbiotics. Journal of Immunology and Clinical Microbiology, 10(1), 1-2. https://izlik.org/JA77YZ24RS
AMA
1.Aslan İ, Tarhan Çelebi L, Bursalıoğlu E, vd. Novel microbiome friendly purifying oil cleanser formulation with oil-soluble postbiotics. J Immunol Clin Microbiol. 2025;10(1):1-2. https://izlik.org/JA77YZ24RS
Chicago
Aslan, İsmail, Leyla Tarhan Çelebi, Ertugrul Bursalıoğlu, vd. 2025. “Novel microbiome friendly purifying oil cleanser formulation with oil-soluble postbiotics”. Journal of Immunology and Clinical Microbiology 10 (1): 1-2. https://izlik.org/JA77YZ24RS.
EndNote
Aslan İ, Tarhan Çelebi L, Bursalıoğlu E, Çakıcı B, Arslan Aydin M, Ibrahim B, Kurt AA (01 Haziran 2025) Novel microbiome friendly purifying oil cleanser formulation with oil-soluble postbiotics. Journal of Immunology and Clinical Microbiology 10 1 1–2.
IEEE
[1]İ. Aslan vd., “Novel microbiome friendly purifying oil cleanser formulation with oil-soluble postbiotics”, J Immunol Clin Microbiol, c. 10, sy 1, ss. 1–2, Haz. 2025, [çevrimiçi]. Erişim adresi: https://izlik.org/JA77YZ24RS
ISNAD
Aslan, İsmail - Tarhan Çelebi, Leyla - Bursalıoğlu, Ertugrul - Çakıcı, Bekir - Arslan Aydin, Mehtap - Ibrahim, Bashar - Kurt, Ahmet Arif. “Novel microbiome friendly purifying oil cleanser formulation with oil-soluble postbiotics”. Journal of Immunology and Clinical Microbiology 10/1 (01 Haziran 2025): 1-2. https://izlik.org/JA77YZ24RS.
JAMA
1.Aslan İ, Tarhan Çelebi L, Bursalıoğlu E, Çakıcı B, Arslan Aydin M, Ibrahim B, Kurt AA. Novel microbiome friendly purifying oil cleanser formulation with oil-soluble postbiotics. J Immunol Clin Microbiol. 2025;10:1–2.
MLA
Aslan, İsmail, vd. “Novel microbiome friendly purifying oil cleanser formulation with oil-soluble postbiotics”. Journal of Immunology and Clinical Microbiology, c. 10, sy 1, Haziran 2025, ss. 1-2, https://izlik.org/JA77YZ24RS.
Vancouver
1.İsmail Aslan, Leyla Tarhan Çelebi, Ertugrul Bursalıoğlu, Bekir Çakıcı, Mehtap Arslan Aydin, Bashar Ibrahim, Ahmet Arif Kurt. Novel microbiome friendly purifying oil cleanser formulation with oil-soluble postbiotics. J Immunol Clin Microbiol [Internet]. 01 Haziran 2025;10(1):1-2. Erişim adresi: https://izlik.org/JA77YZ24RS

88x31.png 

Creative Commons Attribution Non-Commercial License: The articles in the Journal of Immunology and Clinical Microbiology are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

JICM bir QMEL® Tıp & Yayınevi ürünüdür.